Alessia Ciancio

3.7k total citations
101 papers, 2.2k citations indexed

About

Alessia Ciancio is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Alessia Ciancio has authored 101 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Hepatology, 79 papers in Epidemiology and 11 papers in Infectious Diseases. Recurrent topics in Alessia Ciancio's work include Hepatitis C virus research (73 papers), Liver Disease Diagnosis and Treatment (59 papers) and Hepatitis B Virus Studies (46 papers). Alessia Ciancio is often cited by papers focused on Hepatitis C virus research (73 papers), Liver Disease Diagnosis and Treatment (59 papers) and Hepatitis B Virus Studies (46 papers). Alessia Ciancio collaborates with scholars based in Italy, United States and Germany. Alessia Ciancio's co-authors include Mario Rizzetto, Antonina Smedile, Gian Paolo Caviglia, Mario Rizzetto, Antonella Olivero, Giorgio Maria Saracco, Maria Lorena Abate, Grazia Anna Niro, Rosanna Fontana and Mauro Salizzoni and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Alessia Ciancio

97 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessia Ciancio Italy 24 1.8k 1.8k 180 164 140 101 2.2k
Shinn‐Cherng Chen Taiwan 25 1.9k 1.0× 1.8k 1.0× 123 0.7× 132 0.8× 95 0.7× 117 2.2k
Chao‐Hung Hung Taiwan 29 2.0k 1.1× 2.0k 1.1× 94 0.5× 173 1.1× 216 1.5× 86 2.4k
Shuhei Hige Japan 21 1.5k 0.8× 1.4k 0.8× 93 0.5× 202 1.2× 208 1.5× 66 2.0k
Ming‐Yen Hsieh Taiwan 23 1.8k 1.0× 1.8k 1.0× 116 0.6× 134 0.8× 130 0.9× 112 2.2k
Roberta D’Ambrosio Italy 24 1.6k 0.9× 1.7k 1.0× 94 0.5× 123 0.8× 169 1.2× 104 2.1k
Wan Cheng Chow Singapore 19 3.3k 1.8× 3.4k 1.9× 224 1.2× 151 0.9× 171 1.2× 48 3.9k
Emilia Hadziyannis Greece 24 1.2k 0.7× 1.4k 0.8× 203 1.1× 149 0.9× 148 1.1× 76 1.8k
Tai‐Chung Tseng Taiwan 34 3.4k 1.8× 3.5k 2.0× 237 1.3× 163 1.0× 232 1.7× 166 4.1k
Chih‐Lin Lin Taiwan 30 2.6k 1.4× 2.8k 1.6× 133 0.7× 111 0.7× 269 1.9× 97 3.2k
Linsheng Guo United States 13 1.0k 0.6× 1.0k 0.6× 72 0.4× 254 1.5× 168 1.2× 15 1.5k

Countries citing papers authored by Alessia Ciancio

Since Specialization
Citations

This map shows the geographic impact of Alessia Ciancio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Ciancio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Ciancio more than expected).

Fields of papers citing papers by Alessia Ciancio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Ciancio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Ciancio. The network helps show where Alessia Ciancio may publish in the future.

Co-authorship network of co-authors of Alessia Ciancio

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Ciancio. A scholar is included among the top collaborators of Alessia Ciancio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Ciancio. Alessia Ciancio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caviglia, Gian Paolo, Piero Fariselli, Roberta D’Ambrosio, et al.. (2024). Development and Validation of a PIVKA‐II‐Based Model for HCC Risk Stratification in Patients With HCV‐Related Cirrhosis Successfully Treated With DAA. Alimentary Pharmacology & Therapeutics. 61(3). 538–549. 2 indexed citations
2.
Caviglia, Gian Paolo, Marta Vernero, Angelo Armandi, et al.. (2023). Prevalence of Multiple Sclerosis in Patients with Inflammatory Bowel Disease. SHILAP Revista de lepidopterología. 5(3). 287–295. 1 indexed citations
3.
Concerto, Carmen, Maria Salvina Signorelli, Alessia Ciancio, et al.. (2023). Transcranial Magnetic Stimulation for the treatment of Gambling Disorder: a systematic review. 1 indexed citations
4.
Ciancio, Alessia, Davide Giuseppe Ribaldone, Alessandra Risso, et al.. (2023). Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study. Biomedicines. 11(1). 166–166. 11 indexed citations
5.
Stroffolini, Tommaso, Alessia Ciancio, Alessandro Federico, et al.. (2023). Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic. European Journal of Clinical Microbiology & Infectious Diseases. 42(8). 945–950. 1 indexed citations
6.
Cusato, Jessica, Lucio Boglione, Amedeo De Nicolò, et al.. (2022). Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. Pharmaceuticals. 15(3). 355–355. 2 indexed citations
7.
Borghi, Claudio, Alessia Ciancio, Ivan Gentile, et al.. (2022). Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project. Journal of Clinical Medicine. 11(23). 6946–6946. 1 indexed citations
8.
Ciancio, Alessia. (2021). Impact of direct antiviral agents (DAAs) on B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C. Minerva Gastroenterology. 67(3). 227–233. 3 indexed citations
9.
Caviglia, Gian Paolo, Antonella Olivero, Alessia Ciancio, et al.. (2020). Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection. Diagnostic Microbiology and Infectious Disease. 96(4). 114985–114985. 14 indexed citations
10.
Rosso, Chiara, Gian Paolo Caviglia, Alessia Ciancio, et al.. (2019). Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study. Minerva Medica. 110(5). 401–409. 12 indexed citations
11.
Cocito, Dario, et al.. (2019). A deceiving case of paraplegia. Internal and Emergency Medicine. 15(3). 473–478. 1 indexed citations
12.
Niro, Grazia Anna, Antonina Smedile, Rosanna Fontana, et al.. (2016). HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response. Alimentary Pharmacology & Therapeutics. 44(6). 620–628. 40 indexed citations
13.
Mangia, Alessandra, Giovanni Cenderello, A. Orlandini, et al.. (2014). Individualized Treatment of Genotype 1 Naïve Patients: An Italian Multicenter Field Practice Experience. PLoS ONE. 9(10). e110284–e110284. 7 indexed citations
14.
Ciancio, Alessia & Mario Rizzetto. (2013). Chronic hepatitis D at a standstill: where do we go from here?. Nature Reviews Gastroenterology & Hepatology. 11(1). 68–71. 33 indexed citations
15.
D’Avolio, Antonio, Alessia Ciancio, Amedeo De Nicolò, et al.. (2012). F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy. Digestive and Liver Disease. 44. S42–S42. 4 indexed citations
16.
Bonardi, R, et al.. (2011). Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin. Biomedicine & Pharmacotherapy. 65(4). 303–306. 5 indexed citations
17.
Ciancio, Alessia & Mario Rizzetto. (2010). Thymalfasin in the treatment of hepatitis B and C. Annals of the New York Academy of Sciences. 1194(1). 141–146. 13 indexed citations
18.
Ciancio, Alessia, Antonina Smedile, Chiara Giordanino, et al.. (2006). Long-Term Follow-Up of Previous Hepatitis C Virus Positive Nonresponders to Interferon Monotherapy Successfully Retreated with Combination Therapy: Are They Really Cured?. The American Journal of Gastroenterology. 101(8). 1811–1816. 16 indexed citations
19.
Masia, Giuseppina, Angela Ingianni, Luigi Demelia, et al.. (2001). TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses. Journal of Viral Hepatitis. 8(5). 384–390. 20 indexed citations
20.
Marzano, Alfredo, Mauro Salizzoni, W. Debernardi‐Venon, et al.. (2001). Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. Journal of Hepatology. 34(6). 903–910. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinn‐Cherng Chen Breakdown of academic impact, for papers by Chao‐Hung Hung Breakdown of academic impact, for papers by Shuhei Hige Breakdown of academic impact, for papers by Ming‐Yen Hsieh Breakdown of academic impact, for papers by Roberta D’Ambrosio Breakdown of academic impact, for papers by Wan Cheng Chow Breakdown of academic impact, for papers by Emilia Hadziyannis Breakdown of academic impact, for papers by Tai‐Chung Tseng Breakdown of academic impact, for papers by Chih‐Lin Lin Breakdown of academic impact, for papers by Linsheng Guo
Rankless by CCL
2026